This inventor holds 1 USPTO granted patent. Top assignees: Harvard College, The Brigham and Women's Hospital, Inc.. Active years: 2016.
Company Filing History:
1 out of 3,071 
1 out of 1,424 
Years Active: 2016
Title: The Innovations of Daniel E. Herman
Introduction
Daniel E. Herman is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cardiology through his innovative research and patents. His work focuses on understanding the genetic factors that contribute to dilated cardiomyopathy, a serious heart condition.
Latest Patents
One of Daniel E. Herman's key patents is titled "Structural mutations in titin cause dilated cardiomyopathy." This patent provides diagnostic markers and methods for identifying individuals who may have an increased susceptibility to developing or currently have dilated cardiomyopathy. The method involves determining if the subject has a mutation in the TTN nucleic acid or titin polypeptide. Additionally, the patent outlines methods for treating subjects who are at risk of or have been diagnosed with this condition.
Career Highlights
Throughout his career, Daniel E. Herman has worked with prestigious institutions such as Brigham and Women's Hospital and Harvard College. His research has been instrumental in advancing the understanding of genetic mutations related to heart diseases.
Collaborations
Daniel has collaborated with esteemed colleagues, including Jonathan G. Seidman and Christine E. Seidman. Their joint efforts have contributed to significant advancements in the field of cardiology.
Conclusion
Daniel E. Herman's innovative work and patent contributions have made a lasting impact on the understanding and treatment of dilated cardiomyopathy. His dedication to research continues to inspire advancements in medical science.